KRAS and malignant colon neoplasm: Genetic mutation analysis revealed variations in the frequency of mutations in colon cancer genes in the two groups [18], including APC (69 vs. 73%), TP53 (55 vs. 50%), KRAS (44 vs. 42%), and PIK3CA (28 vs. 32%) (Fig. 7D).